Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02763202 · ClinicalTrials.gov registry record · NA
Aiming to Improve Readmissions Through InteGrated Hospital Transitions
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,876
- Enrollment target
NCT02763202 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,876 participants.
The verdict
NCT02763202, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,876 participants
- Enrollment target
Study Summary
The purpose of this study is to better enhance transitions of care for the highest risk, complex patients, Carolinas HealthCare System (CHS) has designed an Integrated Practice Unit, called Transition Services (CHS-TS).CHS-TS aims to improve patient outcomes through innovative approaches that leverage analytics and technology, while bridging care coordination and communication gaps. During their hospitalization, CHS-TS patients enter into a transition pathway that includes the following key services: integrated access to medical, pharmacist, and specialty providers; access to CHS disease specific management programs; dedicated care management services delivered in home and at the clinic; lab and infusion services; palliative care consultations when appropriate; and paramedicine for 24 hour support. AIRTIGHT (Aiming to Improve Readmissions Through InteGrated Hospital Transitions) is a pragmatic, randomized quality improvement evaluation, which seeks to evaluate the effects of the role-out of CHS-TS services for patients at high risk for a 30-day readmission. AIRTIGHT will test the hypothesis that patients that receive care through CHS-TS will have a lower all cause, 30-day readmission rate than patients that receive usual care.
Interventions
- OTHER CHS Transition Services
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,876 participants |
| Start Date | 2016-02-08 |
| Est. Completion | 2017-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02763202
The ClinicalTrials.gov registry entry for NCT02763202 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,876 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CHS Transition Services is the first listed.
NCT02763202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02763202 about?
NCT02763202 is a clinical study titled "Aiming to Improve Readmissions Through InteGrated Hospital Transitions". The purpose of this study is to better enhance transitions of care for the highest risk, complex patients, Carolinas HealthCare System (CHS) has designed an Integrated Practice Unit, called Transition Services (CHS-TS).CHS-TS aims to improve patient outcomes through innovative approaches that levera...
What is the current status of trial NCT02763202?
This trial is currently completed. It is a NA study. The enrollment target is 1,876 participants. The study started on 2016-02-08. Estimated completion is 2017-04-30.
What interventions are being tested in trial NCT02763202?
The interventions under investigation include: CHS Transition Services (OTHER).
Who is sponsoring clinical trial NCT02763202?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.